Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Director departure
Ocugen, Inc. (HSGX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Ocugen Mucosal Vaccine Candidate OCU500 Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials"
08/22/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "MODIFIER GENE M GENE M"
08/21/2023 8-K Quarterly results
Docs: "Ocugen Provides Business Update with Second Quarter 2023 Financial Results"
08/21/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/15/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/15/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/07/2023 SC 13G/A BlackRock Inc. reports a 1.5% stake in Ocugen, Inc.
06/09/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/25/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "FORM 8-K",
"Underwriting Agreement",
"11 Great Valley Parkway"
05/25/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/24/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/23/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/17/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/11/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/08/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/05/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/05/2023 8-K Quarterly results
05/05/2023 8-K Quarterly results
04/24/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/20/2023 ARS Form ARS - Annual Report to Security Holders:
04/20/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/14/2023 8-K Quarterly results
03/13/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "SECURITIES AND EXCHANGE COMMISSION",
"Courageous Innovation March 2023 NASDAQ: OCGN Forward Looking Statements 2 This"
03/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FORM 8-K"
03/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FORM 8-K"
02/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/28/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/28/2023 10-K Annual Report for the period ended December 31, 2022
02/28/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Ocugen Provides Business Update with Fourth Quarter and Full Year 2022 Financial Results",
"Full Year 2022 Business Update February 28, 2023 NASDAQ:OCGN"
02/28/2023 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "SECURITIES AND EXCHANGE COMMISSION",
"Courageous Innovation February 2023 NASDAQ: OCGN Forward Looking Statements 2 This"
01/09/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "SECURITIES AND EXCHANGE COMMISSION",
"Courageous Innovation January 2023 NASDAQ: OCGN Forward Looking Statements 2 This"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy